Pulmonary Arterial Hypertension Oral and Inhaled Drugs

• PAH Class Update/New Drug Eval - Dec 05, 2024
• Pulmonary Hypertension - Oct 07, 2021
• Pulmonary Hypertension Class Update - Sep 27, 2018

• Drugs for Pulmonary Arterial Hypertension - Mar 31, 2016
• Pulmonary Arterial Hypertension Class Update - Jul 31, 2014
• Abbreviated Class Review: Intraveneous/Subcutaneous Pulmonary Arterial Hypertension (PAH) Agents - Sep 27, 2012
• Class Scan: Pulmonary Arterial Hypertension Agents - Apr 26, 2012

• PAH Drug Use Review - Dec 05, 2024

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.